Epistaxis epidemiology and demographics

Revision as of 21:03, 15 October 2020 by Amir Bagheri (talk | contribs)
Jump to navigation Jump to search

Epistaxis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Epistaxis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Epistaxis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Epistaxis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Epistaxis epidemiology and demographics

CDC on Epistaxis epidemiology and demographics

Epistaxis epidemiology and demographics in the news

Blogs on Epistaxis epidemiology and demographics

Directions to Hospitals Treating Epistaxis

Risk calculators and risk factors for Epistaxis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D.

Overview

Epistaxis is a very prevalent symptom in general populations worldwide. About 60 percent of people experienced epistaxis at least once, and about 6 percent of people looking for medical action at least once. It is more common in children and elderly patients

Epidemiology and demographics

The incidence of patients with epistaxis, which needed inpatients treatment to control bleeding was estimated to be 42 cases per 100,000 for men, 28 cases per 100,000 for women and for men over 85 years it's 222 per 100,000 in Thuringia, Germany.[1]

"About 1 in 200 visits of emergency departments, is for epistaxis In the United States".[2]

Prevalence

About 60 percent of American people experienced epistaxis at least once, and about 6 percent of people looking for medical action. [3]

Case-fatality rate/Mortality rate

Although epistaxis is the most common emergency in ENT, mortality from epistaxis is rare. [4]

Age

Patients of all age groups may experience epistaxis, but it is more prevalent in children and elderly patients.[2]

Race

Based on some studies epistaxis is more common in Caucasian compared with African-Americans.[5]

Gender

Epistaxis is more common in males.[6]


References

  1. Kallenbach, Max; Dittberner, Andreas; Boeger, Daniel; Buentzel, Jens; Kaftan, Holger; Hoffmann, Kerstin; Jecker, Peter; Mueller, Andreas; Radtke, Gerald; Guntinas-Lichius, Orlando (2020). "Hospitalization for epistaxis: a population-based healthcare research study in Thuringia, Germany". European Archives of Oto-Rhino-Laryngology. 277 (6): 1659–1666. doi:10.1007/s00405-020-05875-2. ISSN 0937-4477.
  2. 2.0 2.1 Pallin, Daniel J.; Chng, Yi-Mei; McKay, Mary Patricia; Emond, Jennifer A.; Pelletier, Andrea J.; Camargo, Carlos A. (2005). "Epidemiology of Epistaxis in US Emergency Departments, 1992 to 2001". Annals of Emergency Medicine. 46 (1): 77–81. doi:10.1016/j.annemergmed.2004.12.014. ISSN 0196-0644.
  3. Tunkel, David E.; Anne, Samantha; Payne, Spencer C.; Ishman, Stacey L.; Rosenfeld, Richard M.; Abramson, Peter J.; Alikhaani, Jacqueline D.; Benoit, Margo McKenna; Bercovitz, Rachel S.; Brown, Michael D.; Chernobilsky, Boris; Feldstein, David A.; Hackell, Jesse M.; Holbrook, Eric H.; Holdsworth, Sarah M.; Lin, Kenneth W.; Lind, Meredith Merz; Poetker, David M.; Riley, Charles A.; Schneider, John S.; Seidman, Michael D.; Vadlamudi, Venu; Valdez, Tulio A.; Nnacheta, Lorraine C.; Monjur, Taskin M. (2020). "Clinical Practice Guideline: Nosebleed (Epistaxis)". Otolaryngology–Head and Neck Surgery. 162 (1_suppl): S1–S38. doi:10.1177/0194599819890327. ISSN 0194-5998.
  4. Anghel AG, Soreanu CC, Dumitru M, Anghel I (2014). "Treatment Options for Severe Epistaxis, the Experience of Coltea ENT Clinic". Maedica (Buchar). 9 (2): 179–82. PMC 4296762. PMID 25705275.
  5. Mauer, A. C.; Khazanov, N. A.; Levenkova, N.; Tian, S.; Barbour, E. M.; Khalida, C.; Tobin, J. N.; Coller, B. S. (2011). "Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults". Journal of Thrombosis and Haemostasis. 9 (1): 100–108. doi:10.1111/j.1538-7836.2010.04105.x. ISSN 1538-7933.
  6. Côrte, Filipa Camacho; Orfao, Tiago; Dias, Cláudia Camila; Moura, Carla Pinto; Santos, Margarida (2018). "Risk factors for the occurrence of epistaxis: Prospective study". Auris Nasus Larynx. 45 (3): 471–475. doi:10.1016/j.anl.2017.07.021. ISSN 0385-8146.

Template:WikiDoc Sources